These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34446027)

  • 1. Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study.
    Zarei Ghobadi M; Emamzadeh R; Teymoori-Rad M; Mozhgani SH
    Virol J; 2021 Aug; 18(1):175. PubMed ID: 34446027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM/TSP).
    Zarei Ghobadi M; Emamzadeh R
    PLoS One; 2022; 17(1):e0262739. PubMed ID: 35041720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL).
    Zarei-Ghobadi M; Sheikhi M; Teymoori-Rad M; Yaslianifard S; Norouzi M; Yaslianifard S; Faraji R; Farahmand M; Bayat S; Jafari M; Mozhgani SH
    BMC Res Notes; 2021 Mar; 14(1):109. PubMed ID: 33757561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.
    Benencio P; Fraile Gonzalez SA; Ducasa N; Page K; Berini CA; Biglione MM
    Retrovirology; 2020 Sep; 17(1):29. PubMed ID: 32883310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
    Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
    J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An insight to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis.
    Mozhgani SH; Piran M; Zarei-Ghobadi M; Jafari M; Jazayeri SM; Mokhtari-Azad T; Teymoori-Rad M; Valizadeh N; Farajifard H; Mirzaie M; Khamseh A; Rafatpanah H; Rezaee SA; Norouzi M
    Retrovirology; 2019 Dec; 16(1):46. PubMed ID: 31888669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-lymphotropic virus 1 (HTLV-1) pathogenesis: A systems virology study.
    Mozhgani SH; Zarei-Ghobadi M; Teymoori-Rad M; Mokhtari-Azad T; Mirzaie M; Sheikhi M; Jazayeri SM; Shahbahrami R; Ghourchian H; Jafari M; Rezaee SA; Norouzi M
    J Cell Biochem; 2018 May; 119(5):3968-3979. PubMed ID: 29227540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nagasaka M; Yamagishi M; Yagishita N; Araya N; Kobayashi S; Makiyama J; Kubokawa M; Yamauchi J; Hasegawa D; Coler-Reilly ALG; Tsutsumi S; Uemura Y; Arai A; Takata A; Inoue E; Hasegawa Y; Watanabe T; Suzuki Y; Uchimaru K; Sato T; Yamano Y
    Proc Natl Acad Sci U S A; 2020 May; 117(21):11685-11691. PubMed ID: 32393644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions.
    Tarokhian H; Rahimi H; Mosavat A; Shirdel A; Rafatpanah H; Akbarin MM; Bari A; Ramezani S; Rezaee SA
    BMC Cancer; 2018 Dec; 18(1):1287. PubMed ID: 30577817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Interleukin-17 cytokine family in human T-cell lymphotropic virus type 1 (HTLV-1) infection and associated diseases.
    Shafiei M; Ghadimi S; Baharlou P; Moghimi F; Letafati A; Mozhgani SH
    Cytokine; 2024 Oct; 182():156710. PubMed ID: 39089216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding dysregulated angiogenesis in HTLV-1 asymptomatic carriers compared to healthy individuals.
    Letafati A; Mozhgani SH; Marjani A; Amiri A; Siami Z; Mohammaditabar M; Molaverdi G; Hedayatyaghoobi M
    Med Oncol; 2023 Oct; 40(11):317. PubMed ID: 37792095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T helper type 9 cell response and its role in the neurological clinic of patients with Human T-lymphotropic virus 1.
    de Sena Rodrigues Júnior R; Antonia Nunes Gomes J; Alberto da Silva Dias G; Fujihara S; Toshimitsu Yoshikawa G; Vilela Lopes Koyama R; Catarina Medeiros Sousa R; Antonio Simões Quaresma J; Thais Fuzii H
    Immunobiology; 2023 Nov; 228(6):152740. PubMed ID: 37657359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of dysregulated pathways underlying HTLV-1-associated myelopathy/tropical spastic paraparesis through co-expression network analysis.
    Zarei Ghobadi M; Mozhgani SH; Erfani Y
    J Neurovirol; 2021 Dec; 27(6):820-830. PubMed ID: 33405203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S
    Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
    Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
    J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mirror like expression of genes involved in the FOXO signaling pathway could be effective in the pathogenesis of human lymphotropic virus type 1 (HTLV-1) through disruption of the downstream pathways.
    Yaslianifard S; Movahedi M; Yaslianifard S; Mozhgani SH
    BMC Res Notes; 2023 Jul; 16(1):147. PubMed ID: 37461070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL).
    Ahmadi Ghezeldasht S; Blackbourn DJ; Mosavat A; Rezaee SA
    Crit Rev Clin Lab Sci; 2023 May; 60(3):189-211. PubMed ID: 36593730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) progression.
    Gomes YCP; Freitas NL; Souza FS; Sandim V; Pereira DA; Nogueira FCS; Echevarria-Lima J; Leite ACCB; Lima MASD; Silva MTT; Araújo AQC; Vicente ACP; Espíndola OM
    Front Immunol; 2022; 13():949516. PubMed ID: 36052089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.